{"entity":{"type":"insider","cik":"0001522046","url":"/insider/0001522046","json_url":"/insider/0001522046.json","name":"Taylor Beth A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":10,"first":"2018-08-22","last":"2026-02-19","span_basis":"filed_date"},"name_variants":[{"name":"Taylor Beth A.","source":"filing","n_filings":1,"first_seen":"2026-02-19","last_seen":"2026-02-19"},{"name":"Taylor Beth","source":"filing","n_filings":9,"first_seen":"2018-08-22","last_seen":"2025-02-20"}],"transactions":[{"id":5871626,"accession":"0001522046-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001522046-26-000002","line_url":"/filing/0001522046-26-000002#line-1","is_derivative":false,"issuer_cik":"0000720154","issuer_name":"Inotiv, Inc.","issuer_ticker":"NOTV","issuer_name_source":null,"issuer_url":"/issuer/0000720154","owner_cik":"0001522046","owner_name":"Taylor Beth A.","owner_url":"/insider/0001522046","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2888.0,"shares_display":"2,888","price_per_share":0.2929,"price_display":"0.29","price_state":"stated","total_value":845.8952,"total_display":"845.90","shares_owned_after":145480.0,"shares_owned_after_display":"145,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-19","scope":"insider"},{"id":4838130,"accession":"0001062993-25-003060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-003060","line_url":"/filing/0001062993-25-003060#line-1","is_derivative":false,"issuer_cik":"0000720154","issuer_name":"Inotiv, Inc.","issuer_ticker":"NOTV","issuer_name_source":null,"issuer_url":"/issuer/0000720154","owner_cik":"0001522046","owner_name":"Taylor Beth","owner_url":"/insider/0001522046","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4370.0,"shares_display":"4,370","price_per_share":4.0061,"price_display":"4.01","price_state":"stated","total_value":17506.657,"total_display":"17,506.66","shares_owned_after":108368.0,"shares_owned_after_display":"108,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-20","scope":"insider"},{"id":4621660,"accession":"0001062993-25-001624","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-001624","line_url":"/filing/0001062993-25-001624#line-1","is_derivative":false,"issuer_cik":"0000720154","issuer_name":"Inotiv, Inc.","issuer_ticker":"NOTV","issuer_name_source":null,"issuer_url":"/issuer/0000720154","owner_cik":"0001522046","owner_name":"Taylor Beth","owner_url":"/insider/0001522046","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2054.0,"shares_display":"2,054","price_per_share":4.465,"price_display":"4.46","price_state":"stated","total_value":9171.11,"total_display":"9,171.11","shares_owned_after":112738.0,"shares_owned_after_display":"112,738","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-31","filed_date":"2025-02-04","scope":"insider"},{"id":6916343,"accession":"0001179110-22-001480","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-22-001480","line_url":"/filing/0001179110-22-001480#line-1","is_derivative":false,"issuer_cik":"0000720154","issuer_name":"Inotiv, Inc.","issuer_ticker":"NOTV","issuer_name_source":null,"issuer_url":"/issuer/0000720154","owner_cik":"0001522046","owner_name":"Taylor Beth","owner_url":"/insider/0001522046","role":"Officer (VP- Finance & CFO)","officer_title":"VP- Finance & CFO","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":23.0715,"price_display":"23.07","price_state":"stated","total_value":115357.5,"total_display":"115,357.50","shares_owned_after":83875.0,"shares_owned_after_display":"83,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-18","filed_date":"2022-02-22","scope":"insider"},{"id":5152009,"accession":"0001179110-21-005394","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-21-005394","line_url":"/filing/0001179110-21-005394#line-1","is_derivative":false,"issuer_cik":"0000720154","issuer_name":"Inotiv, Inc.","issuer_ticker":"NOTV","issuer_name_source":null,"issuer_url":"/issuer/0000720154","owner_cik":"0001522046","owner_name":"Taylor Beth","owner_url":"/insider/0001522046","role":"Officer (VP- Finance & CFO)","officer_title":"VP- Finance & CFO","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2154.0,"shares_display":"2,154","price_per_share":23.14,"price_display":"23.14","price_state":"stated","total_value":49843.56,"total_display":"49,843.56","shares_owned_after":37329.0,"shares_owned_after_display":"37,329","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-13","filed_date":"2021-05-17","scope":"insider"},{"id":4174385,"accession":"0001179110-21-002958","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-21-002958","line_url":"/filing/0001179110-21-002958#line-1","is_derivative":false,"issuer_cik":"0000720154","issuer_name":"BIOANALYTICAL SYSTEMS INC","issuer_ticker":"BASI","issuer_name_source":null,"issuer_url":"/issuer/0000720154","owner_cik":"0001522046","owner_name":"Taylor Beth","owner_url":"/insider/0001522046","role":"Officer (VP- Finance & CFO)","officer_title":"VP- Finance & CFO","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":17.7,"price_display":"17.70","price_state":"stated","total_value":88500.0,"total_display":"88,500.00","shares_owned_after":34295.0,"shares_owned_after_display":"34,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-05","scope":"insider"},{"id":2651249,"accession":"0001179110-20-006457","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-20-006457","line_url":"/filing/0001179110-20-006457#line-3","is_derivative":false,"issuer_cik":"0000720154","issuer_name":"BIOANALYTICAL SYSTEMS INC","issuer_ticker":"BASI","issuer_name_source":null,"issuer_url":"/issuer/0000720154","owner_cik":"0001522046","owner_name":"Taylor Beth","owner_url":"/insider/0001522046","role":"Officer (VP- Finance & CFO)","officer_title":"VP- Finance & CFO","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3300.0,"shares_display":"3,300","price_per_share":4.52,"price_display":"4.52","price_state":"stated","total_value":14916.0,"total_display":"14,916.00","shares_owned_after":13300.0,"shares_owned_after_display":"13,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-21","filed_date":"2020-05-21","scope":"insider"},{"id":2651246,"accession":"0001179110-20-006457","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-006457","line_url":"/filing/0001179110-20-006457#line-2","is_derivative":false,"issuer_cik":"0000720154","issuer_name":"BIOANALYTICAL SYSTEMS INC","issuer_ticker":"BASI","issuer_name_source":null,"issuer_url":"/issuer/0000720154","owner_cik":"0001522046","owner_name":"Taylor Beth","owner_url":"/insider/0001522046","role":"Officer (VP- Finance & CFO)","officer_title":"VP- Finance & CFO","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4933.0,"shares_display":"4,933","price_per_share":4.42,"price_display":"4.42","price_state":"stated","total_value":21803.86,"total_display":"21,803.86","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-20","filed_date":"2020-05-21","scope":"insider"},{"id":2651241,"accession":"0001179110-20-006457","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-006457","line_url":"/filing/0001179110-20-006457#line-1","is_derivative":false,"issuer_cik":"0000720154","issuer_name":"BIOANALYTICAL SYSTEMS INC","issuer_ticker":"BASI","issuer_name_source":null,"issuer_url":"/issuer/0000720154","owner_cik":"0001522046","owner_name":"Taylor Beth","owner_url":"/insider/0001522046","role":"Officer (VP- Finance & CFO)","officer_title":"VP- Finance & CFO","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5067.0,"shares_display":"5,067","price_per_share":4.38,"price_display":"4.38","price_state":"stated","total_value":22193.46,"total_display":"22,193.46","shares_owned_after":5067.0,"shares_owned_after_display":"5,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-19","filed_date":"2020-05-21","scope":"insider"},{"id":6579284,"accession":"0001179110-18-012090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-012090","line_url":"/filing/0001179110-18-012090#line-1","is_derivative":false,"issuer_cik":"0001235007","issuer_name":"ENDOCYTE INC","issuer_ticker":"ECYT","issuer_name_source":null,"issuer_url":"/issuer/0001235007","owner_cik":"0001522046","owner_name":"Taylor Beth","owner_url":"/insider/0001522046","role":"Officer (VP Finance & Chief Acctg Offcr)","officer_title":"VP Finance & Chief Acctg Offcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7022.0,"shares_display":"7,022","price_per_share":15.5635,"price_display":"15.56","price_state":"stated","total_value":109286.897,"total_display":"109,286.90","shares_owned_after":56341.0,"shares_owned_after_display":"56,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-05","filed_date":"2018-10-09","scope":"insider"},{"id":6136757,"accession":"0001179110-18-010987","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-010987","line_url":"/filing/0001179110-18-010987#line-1","is_derivative":false,"issuer_cik":"0001235007","issuer_name":"ENDOCYTE INC","issuer_ticker":"ECYT","issuer_name_source":null,"issuer_url":"/issuer/0001235007","owner_cik":"0001522046","owner_name":"Taylor Beth","owner_url":"/insider/0001522046","role":"Officer (VP Finance & Chief Acctg Offcr)","officer_title":"VP Finance & Chief Acctg Offcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7892.0,"shares_display":"7,892","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":157840.0,"total_display":"157,840.00","shares_owned_after":63363.0,"shares_owned_after_display":"63,363","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-28","filed_date":"2018-08-29","scope":"insider"},{"id":6513443,"accession":"0001179110-18-010754","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-010754","line_url":"/filing/0001179110-18-010754#line-1","is_derivative":false,"issuer_cik":"0001235007","issuer_name":"ENDOCYTE INC","issuer_ticker":"ECYT","issuer_name_source":null,"issuer_url":"/issuer/0001235007","owner_cik":"0001522046","owner_name":"Taylor Beth","owner_url":"/insider/0001522046","role":"Officer (VP Finance & Chief Acctg Offcr)","officer_title":"VP Finance & Chief Acctg Offcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":285.0,"shares_display":"285","price_per_share":18.2001,"price_display":"18.20","price_state":"stated","total_value":5187.0285,"total_display":"5,187.03","shares_owned_after":71255.0,"shares_owned_after_display":"71,255","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-20","filed_date":"2018-08-22","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000720154","name":"Inotiv, Inc.","url":"/issuer/0000720154","role":"Officer (Chief Financial Officer)","n_filings":7,"first_seen":"2020-05-21","last_seen":"2026-02-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001235007","name":"ENDOCYTE INC","url":"/issuer/0001235007","role":"Officer (VP Finance & Chief Acctg Offcr)","n_filings":3,"first_seen":"2018-08-22","last_seen":"2018-10-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001522046","retrieved_at":"2026-08-22T03:34:12+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}